![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche Announces Positive Topline Results](https://a.storyblok.com/f/176343/1920x1281/8abca57422/roche_270585.jpeg)
glp 1 roche
Shipping Estimate
glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche Announces Positive Topline Results
EUR22.13
EUR64.13
Pay in 4 interest-free payments of $5.53 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche Announces Positive Topline Results](https://cdn.sanity.io/images/0vv8moc6/pharmexec/a423b703669ea858bb2ce82a2711e9eda7287296-1280x720.png/drug%20discovery%20partnership%2016x9.png?w=1280&max-h=720&fit=crop&auto=format)
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche Announces Positive Topline Results](https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-861888890.jpg?VersionId=dYoUH7WUs_4rWDQ5OEdz9yfA6rL4ZLIL)
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche Announces Positive Topline Results](https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-1812040254%20%281%29.jpg?VersionId=idd_CDc5t_JQ44nQ1BNBX6PQ__RT5x2Q)
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche Announces Positive Topline Results](https://www.reuters.com/resizer/v2/BIPB7PT57RJYJJHFU5PF72AIEQ.jpg?auth=5f9ccaafec8ed2e625cc21771bccedbf19861af17e1ca0562b48356be033c9f7&width=1200&quality=80)
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche Announces Positive Topline Results](https://imgproxy.divecdn.com/Uen3WaSRQrS4Q4Ruldy39jm7wp7yZKOh-bFeEbuMcFE/g:ce/rs:fill:1200:675:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTUwMDMzMjU3LmpwZw==.webp)
